Disease recurrence plays a minor role as a cause for retransplantation after living-donor liver transplantation for primary biliary cirrhosis: A multicenter study in Japan

Hepatology Research

Volumn 43, Issue 5, 2013, Pages 502-507

  Egawa, Hiroto ^a   Nakanuma, Yasuni ^b   Maehara, Yoshihiko ^c   Uemoto, Shinji ^d   Eguchi, Susumu ^e   Sato, Yoshinobu ^f   Shirabe, Ken ^c   Takatsuki, Mitsuhisa ^e   Mori, Akira ^d   Yamamoto, Masakazu ^a   Tsubouchi, Hirohito ^g  

^a TOKYO WOMEN'S MEDICAL UNIVERSITY   (Japan)

^b KANAZAWA UNIVERSITY   (Japan)

^c KYUSHU UNIVERSITY   (Japan)

^d KYOTO UNIVERSITY   (Japan)

^e NAGASAKI UNIVERSITY   (Japan)

^f NIIGATA UNIVERSITY GRADUATE SCHOOL OF MEDICAL AND DENTAL SCIENCES   (Japan)

^g KAGOSHIMA UNIVERSITY   (Japan)

Author keywords

Histology; Living donor liver transplantation; Primary biliary cirrhosis; Recurrence; Retransplantation

Indexed keywords

CYCLOSPORIN; TACROLIMUS; URSODEOXYCHOLIC ACID;

ADULT; ARTICLE; CHRONIC GRAFT REJECTION; FEMALE; GRAFT FAILURE; HUMAN; HUMAN TISSUE; IMMUNOSUPPRESSIVE TREATMENT; JAPAN; LIVER BIOPSY; LIVER TRANSPLANTATION; LIVING DONOR; MAJOR CLINICAL STUDY; MALE; MODEL FOR END STAGE LIVER DISEASE SCORE; MULTICENTER STUDY; PRIMARY BILIARY CIRRHOSIS; PRIORITY JOURNAL; RECURRENT DISEASE; RETRANSPLANTATION;

EID: 84876957475     PISSN: 13866346     EISSN: 1872034X     Source Type: Journal    
DOI: 10.1111/j.1872-034X.2012.01108.x     Document Type: Article

References (18)

1. Silvera MG, Talwalker JA, Lindor KD, Wiesner RH. Recurrent primary biliary cirrhosis after liver transplantation. Am J Transplant 2010; 10: 720-726.
2. Hashimoto E, Shimada M, Noguchi S etal. Disease recurrence after living donor liver transplantation for primary biliary cirrhosis: a clinical and histological follow-up study. Liver Transpl 2001; 7: 588-595.
3. Hashimoto E, Taniai M, Yatsuji S etal. Long-term clinical outcome of living-donor liver transplantation for primary biliary cirrhosis. Hepatol Res 2007; 37: S455-461.
4. Takeishi T, Sato Y, Ichida T, Yamamoto S, Kobayashi T, Hatakeyama K. Short-term outcomes of living-related liver transplantation for primary biliary cirrhosis and its recurrence: report of five cases. Transplant Proc 2003; 35: 372-372.
5. Morioka D, Egawa H, Kasahara M etal. Impact of leukocyte antigen mismatching on outcomes of living donor liver transplantation for primary biliary cirrhosis. Liver Transpl 2007; 13: 80-90.
6. Kaneko J, Sugawara Y, Tamura S etal. Long-term outcome of living donor liver transplantation for primary biliary cirrhosis. Transpl Int 2012; 25: 7-12.
7. Rowe IA, Webb K, Gunson BK, Mehta N, Haque S, Neuberger J. The impact of disease recurrence on graft survival following liver transplantation: a single center experience. Transpl Int 2008; 21: 459-465.
8. Charatcharoenwitthaya P, Pimentel S, Talwalkar JA etal. Longterm survival and impact of ursodeoxycholic acid treatment for recurrent primary biliary cirrhosis after liver transplantation. Liver Transpl 2007; 13: 1236-1245.
9. Hubscher SG, Elias E, Buckels JA, Mayar AD, McMaster P, Neuberger JM. Primary biliary cirrhosis. Histological eveidence od disease recurrence after liver transplantation. J Hepatol 1993; 18: 173-184.
10. Haga H, Miyagawa-Hayashino Aya TK etal. Histological recurrence of autoimmune liver diseases after living-donor liver transplantation. Hepatol Res 2007; 37: S463-S469.
11. International panel. Banff schema for grading liver allograft rejection: an international consensus document. Hepatology 1997; 25: 658-663.
12. Demetris AJ, Adams D, Bellamy C etal. Update of the international banff schema for liver allograft rejection: working recommendation for the histopathologic staging and reporting of chronic rejection. An international panel. Hepatology 2000; 31: 792-799.
13. Nakanuma Y, Zen Y, Harada K etal. Application of a new histological staging and grading system for primary biliary cirrhosis to liver biopsy specimens: Interobserver agreement. Pathol Int 2010; 60: 167-174.
14. Kleiner DE, Brunt EM, Van Natta M etal. Design and validation of a histological scoring system for nonalcoholic fatty liver disease. Hepatology 2005; 41: 1313-1321.
15. Neuberger J. Recurrent primary biliary cirrhosis. Liver Transpl 2003; 9 (6): 539-546.
16. Banff Working Groups, Demetris AJ, Adeyi O, Bellamy CO etal. Liver biopsy interpretation as cause of late liver allograft dysfunction. Hepatology 2006; 44: 489-501.
17. Montano-Loza J, Wasilenko S, Bintner J, Mason AL, Cyclosporine A. Protects against primary biliary cirrhosis recurrence after liver transplantation. Am J Transplant 2010; 10: 852-858.
18. The Japanese Liver Transplant Society. Liver Transplantation in Japan - Registry by the Japanese Liver Transplantation Society. Ishoku 2012; 46: 524-536.